Inflammatory bowel disease: Causes and consequences

Best Practice and Research: Clinical Gastroenterology

Volumn 18, Issue 3, 2004, Pages 447-449

  Hugot, Jean Pierre ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOSUPPRESSIVE AGENT; MUCIN; TUMOR NECROSIS FACTOR ANTIBODY;

CLINICAL FEATURE; COLON MUCOSA; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM FISTULA; EDITORIAL; ENTERITIS; GENETIC PREDISPOSITION; GENETIC SCREENING; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNOREGULATION; PATHOPHYSIOLOGY; PHENOTYPE; RISK FACTOR; ULCERATIVE COLITIS;

HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 2442679298     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2004.02.001     Document Type: Editorial

References (4)

1. Lennard-Jones J.E. Classification of inflammatory bowel disease Scand J Gastroenterol 24 supplement 170 1989 2-6
2. Gasche C. Scholmerich J. Brynskov J. et al. A simple classification of Crohn's disease: report of the working party of the world congresses of gastroenterology, Vienna 1998 Inflamm Bowel Dis 6 2000 8-15
3. Hugot J.P. Chamaillard M. Zouali H. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599-603
4. Ogura Y. Bonen D.K. Inohara N. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 2001 537-539